Catalyst Biosciences logo
Catalyst Biosciences CBIO
€ 9.83 -8.95%

Quartalsbericht 2025-Q3
hinzugefügt 07.11.2025

report update icon

Catalyst Biosciences Kurzfristige Verbindlichkeiten 2011-2026 | CBIO

Kurzfristige Verbindlichkeiten Jährlich Catalyst Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
20 M 12.2 M 14.2 M 17.8 M 28.9 M 4.8 M 8.74 M 22 M 37.8 M 2.34 M 11 M 11.3 M 78.6 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
78.6 M 2.34 M 20.7 M

Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Kurzfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
Biogen Biogen
BIIB
5.53 B $ 173.17 0.92 % $ 25.2 B usaUSA
Adagene Adagene
ADAG
38.2 M $ 2.4 -3.61 % $ 135 M chinaChina
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
4.34 M $ 0.98 1.35 % $ 5.34 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
22.2 M $ 1.77 -2.75 % $ 4.49 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
195 M $ 67.41 0.54 % $ 9.02 B usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
20.2 M $ 2.04 -2.39 % $ 183 M israelIsrael
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.05 M $ 4.36 -2.46 % $ 9.49 B israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
54.1 M - - $ 1.01 B usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
72.8 M - -15.15 % $ 60.3 M britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
174 M $ 26.57 2.51 % $ 1.29 B usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
332 M $ 2.26 9.7 % $ 213 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
1.13 B $ 13.59 1.46 % $ 4.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
4.46 M - -45.71 % $ 1.2 M canadaCanada
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
5.24 M - 4.14 % $ 49.1 M usaUSA
Athira Pharma Athira Pharma
ATHA
13.1 M - - $ 269 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
39.5 M $ 26.72 3.09 % $ 1.72 M usaUSA
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
63.1 M $ 2.75 1.85 % $ 17.3 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
66.3 M - -6.81 % $ 3.04 B usaUSA
Brickell Biotech Brickell Biotech
BBI
1.66 M - -5.38 % $ 6.06 M usaUSA